# Clinical Randomisation of an Antifibrinolytic in Significant Head Injury

> **NCT01402882** · PHASE3 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 12737 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** Tranexamic Acid

## Key facts

- **NCT ID:** NCT01402882
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2019-10
- **Final completion:** 2019-10
- **Target enrollment:** 12737 (ACTUAL)
- **Last updated:** 2020-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01402882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01402882, "Clinical Randomisation of an Antifibrinolytic in Significant Head Injury". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01402882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*